Double-Blind Cross over Treatment with Mesterolone and Placebo of Subfertile Oligozoospermic Men Value of Testicular Biopsy
- 24 April 2009
- journal article
- clinical trial
- Published by Hindawi Limited in Andrologia
- Vol. 15 (S1) , 531-535
- https://doi.org/10.1111/j.1439-0272.1983.tb00206.x
Abstract
Fifty-nine carefully selected oligozoospermic men were randomly treated with mesterolone (75 mg/day) or placebo to improve fertility. After 6 months the medication was changed from mesterolone to placebo or vice versa. Fourteen pregnancies occurred, 7 under mesterolone and 7 under placebo. A testicular biopsy score was of prognostic value: the men who impregnated their partner had a significantly higher mean score than the men who did not fertilize. No other significant differences between these two groups of men were observed. Mesterolone had no significant influence other than placebo.Keywords
This publication has 5 references indexed in Scilit:
- Value of a testicular biopsy rating for prognosis in oligozoospermia.BMJ, 1978
- SERUM GONADOTROPHINS, TESTOSTERONE AND SPERMATOGENESIS IN SUBFERTILE MENActa Endocrinologica, 1977
- A Relationship Between Testicular Biopsy Score Count and Fertility of Men Treated for OligospermiaFertility and Sterility, 1974
- Testicular Biopsy Score Count – A Method for Registration of Spermatogenesis in Human Testes: Normal Values and Results in 335 Hypogonadal MalesHormone Research in Paediatrics, 1970
- INTERRELATIONSHIPS AMONG THE CHARACTERISTICS OF HUMAN SEMEN AND FACTORS AFFECTING SEMEN-SPECIMEN QUALITYReproduction, 1962